Reg CF · SAFE · Apr 2024

ClosedReached targetReg CFSAFE

via Republic · last checked Oct 8, 2026View campaign

Raised

$66.6K / $548.4K max

12% of ceiling · target hit day 11

Investors

$2K avg

Valuation cap

$8.5M

cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors

$66K$33K$0

31160

Apr 9, 2024 · openedMay 1, 2024 · last reading

Target ($50K) hit — Apr 20, 2024, day 11Deadline Apr 30, 2024

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via Republic, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source

$656K

−$298K

FY2022

$352K

−$802K

FY2023

RevenueNet income

Metric

FY2022 reviewed

FY2023 reviewed

Income statement

Revenue

$656,254

$351,884

Cost of goods sold

$502,706

$316,521

Gross margin

23%

10%

Net income

-$298,107

-$802,218

Taxes paid

Balance sheet

Cash

$430,974

$49,148

Accounts receivable

$14,509

$30,735

Total assets

$524,946

$261,951

Short-term debt

$95,466

$197,983

Long-term debt

$798,690

$1,170,265

Total liabilities

$894,156

$1,368,248

Other

Headcount

—

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$8.5M

Perks

Invest $750, receive one annual TIBU health membership$750+

Offering details

Target$50,000

Max$548,387

Min investment$250

OpenedApr 9, 2024

DeadlineApr 30, 2024

ClosedApr 30, 2024

Days active21

Links & provenance

Campaign page SEC filing

Source: Manual
0001855384-24-000002
Last synced Aug 19, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.